Pharmacists in London, England will receive authorization next year to supply women with the oral contraceptive pill over-the-counter-without the need for a doctor's prescription-as part of a new pilot project.
GlaxoSmithKline's Volibris is a new endothelin receptor antagonist for the treatment of idiopathic (primary) pulmonary arterial hypertension, as well as PAH associated with connective tissue disease.
